Quantum Innovations, a Polish medtech startup, received a grant from the Polish Agency for Enterprise Development under the SMART Path to create a tiny system that continuously measures lactate levels in interstitial fluid in real time.
BIOSINTEX SRL, a Romanian manufacturer of high‑performance surgical sutures, together with technology partner TRICUBIQ SOLUTIONS SRL, has completed a 16‑month project worth 18.07 million lei that automates key production processes through robotics, AI and digital tools. The project, financed by the EU‑backed PNRR, enhances BIOSINTEX’s production capacity, quality control and international market position.
The BioInnovation Institute (BII) announced an additional €7.8 million grant, split as €1.3 million per company, for six Danish spin‑outs working on antibody cancer therapies, AI‑powered ultrasound, inflammatory disease treatments, biological pest control, vaccine‑based immunotherapies, and waste‑to‑fuel technology. The funding builds on a prior €500 k grant each, bringing total support to €1.8 million per company and includes continued access to BII’s Copenhagen innovation platform.
Swiss biotech startup PANDA Therapeutics received a €160,000 grant from Venture Kick to develop a first‑in‑class antibody therapy that simultaneously targets multiple harmful protein deposits in Alzheimer’s disease, aiming to improve treatment effectiveness and slow disease progression.
Swedish startup Readily Diagnostics secured an €811k grant from the Gates Foundation to create a low‑cost, rapid molecular test for common STIs, aiming to make accurate diagnostics accessible worldwide, especially in low‑resource settings.
Lithuanian femtosecond‑laser startup LITILIT secured an €8 million loan from the national development bank to launch a €10 million project that will enable mass production of high‑power femtosecond lasers and the rollout of its modular FEMODA system.
Swedish accounting‑software provider Fortnox has committed 50 million Swedish crowns to the Stockholm School of Economics for a decade‑long research initiative that will investigate the factors behind successful companies.
Luxembourg‑based space biotech startup Exobiosphere received a €1 million grant from the government’s JEI programme to accelerate its commercial activities and develop its orbital high‑throughput screening system for drug discovery in microgravity.
In a EU‑Startups podcast, PrintyMed founder and CEO Jekaterina Romanova discussed the Latvian biotech startup’s biomimetic spider‑silk technology, its €2 million in EU grant funding, and plans to expand into Saudi Arabia while focusing on organ‑on‑a‑chip membranes for drug testing.
Spanish biotech startup Entomonorte, which develops R&D and consulting services for converting bio‑waste into high‑value raw materials, secured a €100,000 grant from the public agency SRP via the Asturias Startup Fund to expand its operations in the region.